Access Program Information
To investigate the clinical outcomes of acute myocardial infarction (AMI) patients with
multivessel disease undergoing percutaneous coronary intervention (PCI) either in
infarct-related artery only or in multivessel in Drug eluting stents (DES) era, using the
everolimus-eluting stent (Promus™ Element™ Stent, Boston Scientific) in real-world clinical
practice.